Related Experiment Video
Updated: May 15, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
Reverse-engineering the genetic circuitry of a cancer cell with predicted intervention in chronic lymphocytic
Laurent Vallat1, Corey A Kemper, Nicolas Jung
1Laboratoire d'Immunogénétique Moléculaire Humaine, Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche S1109, Centre de Recherche d'Immunologie et d'Hématologie, Faculté de Médecine, Université de Strasbourg, Fédération de Médecine Translationnelle de Strasbourg, 67085 Strasbourg Cedex, France.
Abstract:
Cellular behavior is sustained by genetic programs that are progressively disrupted in pathological conditions--notably, cancer. High-throughput gene expression profiling has been used to infer statistical models describing these cellular programs, and development is now needed to guide orientated modulation of these systems. Here we develop a regression-based model to reverse-engineer a temporal genetic program, based on relevant patterns of gene expression after cell stimulation. This method integrates the temporal dimension of biological rewiring of genetic programs and enables the prediction of the effect of targeted gene disruption at the system level. We tested the performance accuracy of this model on synthetic data before reverse-engineering the response of primary cancer cells to a proliferative (protumorigenic) stimulation in a multistate leukemia biological model (i.e., chronic lymphocytic leukemia). To validate the ability of our method to predict the effects of gene modulation on the global program, we performed an intervention experiment on a targeted gene. Comparison of the predicted and observed gene expression changes demonstrates the possibility of predicting the effects of a perturbation in a gene regulatory network, a first step toward an orientated intervention in a cancer cell genetic program.
Insights
This study introduces a new regression model to understand how gene expression changes over time in cancer cells. The model accurately predicts how altering specific genes impacts the entire genetic program, paving the way for targeted cancer therapies.
Area of Science:
- Systems Biology
- Computational Biology
- Genomics
Background:
- Cellular functions rely on genetic programs, which are often disrupted in diseases like cancer.
- Current methods for analyzing gene expression lack the ability to guide targeted interventions in these disrupted systems.
Purpose of the Study:
- To develop a novel regression-based model for reverse-engineering temporal genetic programs.
- To predict the system-level effects of targeted gene disruption.
- To validate the model's predictive power in a cancer cell context.
Main Methods:
- Developed a regression-based computational model to infer temporal gene expression patterns.
- Applied the model to synthetic data for performance assessment.
- Reverse-engineered the genetic program response in primary chronic lymphocytic leukemia cells to proliferative stimulation.
- Performed gene perturbation experiments to validate model predictions.
Main Results:
- The model accurately predicted gene expression changes in synthetic datasets.
- Successfully reverse-engineered the temporal genetic program in chronic lymphocytic leukemia cells.
- Experimental validation confirmed the model's ability to predict the effects of targeted gene modulation.
- Demonstrated the potential for predicting perturbations within a gene regulatory network.
Conclusions:
- The developed model successfully integrates the temporal dynamics of genetic rewiring.
- This approach enables accurate prediction of gene perturbation effects within a biological system.
- Represents a significant step towards developing targeted interventions for cancer genetic programs.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
13:21Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
Published on: June 16, 2017
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...